Clinical presentation of the patient. (A) Genogram for the ERCC6L2-mutated pedigree. The squares denote males, and the circles denote females. The pink arrow shows the proband. The red boxes indicate individuals with MDS/AML. ERCC6L2 mutations were detected in the MDS/AML sample for III-3, but DNA was not available for the other affected individual (III-6). The gray box indicates individuals with detectable ERCC6L2 homozygous mutation without myeloid malignancy (III-1). The hatched box indicates an heterozygous carrier (III-5). No DNA was available from other family members. (B-D) Aspirate showing binuclear erythroblast (A), hyposegmentation of granulocytes (red arrow), (B) and monolobated megakaryocyte; (C) Leishman stained (original magnification ×400 to ×1000). (E) Trephine biopsy showing a hypercellular BM; hematoxylin and eosin–stained section (original magnification ×200). (F) Metaphase representative of the monosomal and complex karyotype 43,XX,der(5)t(5;17)(q14;q21),-7,dic(9;?)(p13;?),-17.- 18[19]/46,XX[1].
Figure 1.

Clinical presentation of the patient. (A) Genogram for the ERCC6L2-mutated pedigree. The squares denote males, and the circles denote females. The pink arrow shows the proband. The red boxes indicate individuals with MDS/AML. ERCC6L2 mutations were detected in the MDS/AML sample for III-3, but DNA was not available for the other affected individual (III-6). The gray box indicates individuals with detectable ERCC6L2 homozygous mutation without myeloid malignancy (III-1). The hatched box indicates an heterozygous carrier (III-5). No DNA was available from other family members. (B-D) Aspirate showing binuclear erythroblast (A), hyposegmentation of granulocytes (red arrow), (B) and monolobated megakaryocyte; (C) Leishman stained (original magnification ×400 to ×1000). (E) Trephine biopsy showing a hypercellular BM; hematoxylin and eosin–stained section (original magnification ×200). (F) Metaphase representative of the monosomal and complex karyotype 43,XX,der(5)t(5;17)(q14;q21),-7,dic(9;?)(p13;?),-17.- 18[19]/46,XX[1].

or Create an Account

Close Modal
Close Modal